Veracyte Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.42 |
Market Cap |
$1.37 B |
Shares Outstanding |
47.97 M |
Public Float |
32.12 M |
Address |
6000 Shoreline Court South San Francisco California 94080 United States |
Employees | - |
Website | http://www.veracyte.com |
Updated | 07/08/2019 |
Veracyte, Inc. engages in the research, development, and commercialization of diagnostic products. Its portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. |